Jefferies Raises NPS Pharmaceuticals (NPSP) Target to $15 after FDA Panel Backing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NPS Pharmaceuticals (NPSP) Mildly Higher after FDA Backing
October 16, 2012 4:21 PM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) resumes after FDA panel backing for Gattex. Shares are currently up about 1% to $10.29.... More
FDA panel backs NPS Pharmaceuticals (NPSP) Gattex
October 16, 2012 3:13 PM EDTFDA panel backs NPS Pharmaceuticals' (NASDAQ: NPSP) Gattex
(NOTE: shares have been halted all day in anticipation of the adcom)... More
